Oral upadacitinib combined with 308-nm excimer light for refractory progressive vitiligo in children and adults：A prospective observational study

Figure 2. Representative clinical photos of refractory vitiligo patients at the baseline and 12-week follow-up. Patient 2 before (A) and after (B) treatment. Patient 13 before (C) and after (D) treatment. Patient 14 before (E) and after (F) treatment.
Table 2: Follow-up to 16 weeks (n = 8), 20 weeks (n = 5), and 24 weeks (n = 3) treatment outcomes of the patients.

图2 难治性白癜风（refractory vitiligo）患者基线状态与12周随访时的典型临床照片：患者2治疗前（图A）与治疗后（图B）、患者13治疗前（图C）与治疗后（图D）、患者14治疗前（图E）与治疗后（图F）。
表2：患者随访至16周（n=8）、20周（n=5）及24周（n=3）的治疗结局。